Is Palisade Bio Inc (NASDAQ: PALI) No Longer A Good Investment?

After Hours

After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Most recently, Yahoo Finance reported about the stock as it publicized that Palisade Bio Reports Year End 2023 Financial Results and Provides Corporate Update.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

Stocks Info

PALI belongs to the Healthcare sector of the NASDAQ while operating in the Biotechnology industry. The current market capitalization of Palisade Bio Inc is $3.70M. A total of 0.13 million shares were traded on the day, compared to an average of 2.72M shares.

In the most recent transaction, Finley John David bought 10,000 shares of PALI for 0.47 per share on Feb 06 ’24. After the transaction, the CEO, CFO, Director now owns 84,649 company shares. In a previous transaction on Jan 31 ’24, Williams Donald Allen bought 10,000 shares at 0.60 per share. PALI shares that Director owns now total 30,000.

Among the insiders who bought shares, Finley John David acquired of 10,000 shares on Jan 31 ’24 at a per-share price of $0.56. This resulted in the CEO, CFO, Director holding 74,649 shares of PALI after the transaction. In another insider transaction, Williams Donald Allen bought 20,000 shares at $0.54 per share on Sep 27 ’23. Company shares held by the Director now total 20,000.

While price targets are rarely accurate, they tend to exert some kind of influence from time to time and are often taken into account by investors. In terms of 52-week highs and lows, PALI has a high of $3.65 and a low of $0.36.

As of this writing, PALI has an earnings estimate of -$0.32 per share for the current quarter. EPS was calculated based on a consensus of 1 estimates, with a high estimate of -$0.32 per share and a lower estimate of -$0.32. The company reported an EPS of -$0.44 in the last quarter, which was -12.80% lower than expectations of -$0.39.

Balance Sheet Annually/Quarterly

An organization’s balance sheet depicts the assets and liabilities it has, as well as the amount of equity invested. Investors can measure a company’s prospects by calculating its financial ratios using this information. PALI’s latest balance sheet shows that the firm has $10.49M in Cash & Short Term Investments as of fiscal 2021. There were $199.00k in debt and $2.50M in liabilities at the time. Its Book Value Per Share was $1.22, while its Total Shareholder’s Equity was $7.37M.

Analysts Opinion

There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for PALI is Buy with a score of 5.00.

Most Popular

Related Posts